Full Text (PDF)
Abstract
Aim: Nowadays, combination of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) with spironolactone is used to treat patients with heart failure or hypertension. Unfortunately these drugs may lead to increase in morbidity and mortality dependent on severe hyperkalemia. We aimed to evaluate the therapeutics and demographic features of patients with hyperkalemia. Methods: 39 patients with hyperkalemia were evaluated retrospectively whom hospitalized with various diagnoses. Results: Mean age and serum potassium level were (20 female and 19 male) 68.3±10.2 years and 6.8±0.7 mmol/L at admission. Twenty one patients (53.8%) used ACEI, ARB or spironolactone. The patients were divided into three groups according to their medications: patients that use anyone of the ACEI, ARB or spironolactone, patients that use combinations of these drugs and patients that do not use these drugs. The prevalence of age and diabetes were significantly high in group I and II (p=0.020 and p=0.034 respectively). Conclusion: In our study mean age and rate of the diabetics were high in group that use ACEI, ARB or spironolactone attract our attention. Therefore, patients should be carefully evaluated about older age and diabetes during prescription of these drugs (alone or in combination).
Keywords
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Original Article
EUR J GEN MED, Volume 5, Issue 2, April 2008, 80-83
https://doi.org/10.29333/ejgm/82582
Publication date: 15 Apr 2008
Article Views: 1575
Article Downloads: 1359
Open Access References How to cite this article